This observational study aims to test proteomics, metabolomics and proteoglycans as predictors of postoperative complications after colorectal surgery and as biomarkers of colorectal cancer. The main questions to answer are: * can these biomarkers predict anastomotic leakages * can these biomarkers predict recurrence after colorectal cancer * can these biomarkers be used as diagnostic tests for colorectal cancer * can these biomarkers be identified in the tumor Participants will undergo elective colorectal resection or stoma closure.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Rate of anastomotic leakage diagnosed by CT-scan or reoperation
Timeframe: 30 days
Rate of major postoperative complications
Timeframe: 30 days
Short-term mortality
Timeframe: 90 days
Recurrence after colorectal cancer
Timeframe: 4 years
Diagnostic value of omics and other biomarkers detecting colorectal cancer
Timeframe: 30 days
Correlation between biomarker in plasma and tissue
Timeframe: 30 days